CLOV (Clover Health Investments) Interest Received


CLOV Clover Health Investments Corp CLOV
82 GF Score
Price $4.72
GF Value $4.01
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Clover Health Investments Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

CLOV
82GF Score
Clover Health Investments Corp CLOV
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Clover Health Investments (CLOV) Overvalued in 2026?

Based on GuruFocus' analysis, Clover Health Investments stock appears to be overvalued. The current stock price of $4.72 is trading 17.6% above its estimated GF Value™ of $4.01. GuruFocus considers Clover Health Investments to be Modestly Overvalued.

Key valuation signals for CLOV:

  • Interest Received:
  • GF Value™: $4.01 vs. price of $4.72 (17.6% above fair value)
  • GF Score™: 82/100 with 3 warning signs

No single metric tells the full story. See the CLOV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Clover Health Investments Business Description

Other Exchanges 7QD:GermanyCLOV34:Brazil
Address 3401 Mallory Lane, Suite 210, Franklin, TN, USA, 37067
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
82GF Score

Get the complete analysis for CLOV

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.72
Price
$4.01
GF Value